Advertisement

Pharmaceutisch Weekblad

, Volume 10, Issue 6, pp 281–283 | Cite as

Pharmacokinetics of three-dose cefoxitin prophylaxis in caesarean section

  • Alphonse J. M. Roex
  • Arie C. van Loenen
Short Communications
  • 22 Downloads

Abstract

A pharmacokinetic analysis of cefoxitin in women undergoing caesarean section under general anaesthesia, was performed. In order to prevent infections postoperatively three doses of cefoxitin -2,1 and 1 g, respectively — were given as a 3-min intravenous infusion at 6-h intervals.In vitro growth of most pathogens is inhibited at a cefoxitin concentration of 16 μg/ml. In the sera of the patients, this antibiotic level was maintained for a period of 90–100 min after the first administration (2 g) and 45–50 min after the second and the third administration of cefoxitin (1 g). The period of subinhibitory antibiotic concentrations lasted 270 and 315 min, respectively. How can one reach prolonged antibiotic coverage? In order to minimize antibiotic pressure on hospital flora it is advisable not to increase the total amount of antibiotic (4 g) administered. By starting a 310 mg/h infusion after the initial 2 g bolus injection, the serum concentration of cefoxitin can be maintained at a minimum level of 16 μg/ml during a period of 6.5 h. The improvement of antibiotic administration suggested requires further clinical testing.

Keywords

Administration, intravenous Cefoxitin Cesarean section Pharmacokinetics Serum concentrations 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gonik B. Single-versus three-dose cefotaxime prophylaxis for caesarean section. Obstet Gynecol 1985;65:189–93.PubMedGoogle Scholar
  2. 2.
    Hawrylyshyn PA, Bernstein P, Papsin FR. Short-term prophylaxis in high-risk patients following caesarean section. Am J Obstet Gynecol 1983;45:285–90.Google Scholar
  3. 3.
    Jaffe R, Altaros M, Ben-Aderet N. Mezlocillin prophylaxis in emergency caesarean section. Chemotherapy 1986;2:173–8.Google Scholar
  4. 4.
    McGregor JA, French JI, Mackowski E. Single-dose cefotetan versus multidose cefoxitin prophylaxis in caesarean section in high-risk patients. Obstet Gynecol 1986;154:955–64.Google Scholar
  5. 5.
    Roex AJM, Puyenbroek JI, Van Loenen AC, Arts NFTh. Single-versus three-dose cefoxitin prophylaxis in caesarean section: a randomized clinical trial. Eur J Obst Gynecol Reprod Biol 1987;25:293–9.Google Scholar
  6. 6.
    Roex AJM, Puyenbroek JI, Maclaren DM, Van Geijn HP, Arts NFTh. A randomised clinical trial of antibiotic prophylaxis in caesarean section: maternal morbidity, risk factors and bacteriological changes. Eur J Obstet Gynecol Reprod Biol 1986;22:117–25.PubMedGoogle Scholar
  7. 7.
    Saltzman DH, Eron LJ, Kay HH, Sites JG. Single-dose antibiotic prophylaxis in high-risk patients undergoing caesarean section. Obstet Gynecol 1985;65:655–8.PubMedGoogle Scholar
  8. 8.
    Varner MW, Weiner CP, Petzold CR, Galask RP. Comparison of cefotetan and cefoxitin as prophylaxis in caesarean section. Am J Obstet Gynecol 1986;154:951–5.PubMedGoogle Scholar
  9. 9.
    Flaherty JF, Boswell GW, Winkel CA, Elliott JP. Pharmacokinetics of cefoxitin in patients at term gestation: lavage versus intravenous administration. Am J Obstet Gynecol 1983;146:760–7.PubMedGoogle Scholar
  10. 10.
    Gonik B, Cotton D, Feldman S, Cleary TG, Pickering K. Comparative pharmacokinetics of cefoxitin in postpartum normotensive and pregnancy-induced hypertension. Am J Obstet Gynecol 1984;148:1088–92.PubMedGoogle Scholar
  11. 11.
    Rouan MC, Abadie F, Leclerq A, Juge F. Systemic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography. J Chromatogr 1983;275:133–45.PubMedGoogle Scholar
  12. 12.
    Van Loenen AC, Roex AJM, Willems HJJ, De Goede PNFC, Van Dijk A. Farmacokinetiek van cefoxitine bij sectio caesarea [Pharmacokinetics of cefoxitin in caesarean section]. Ziekenhuisfarmacie 1987;3:47–51.Google Scholar
  13. 13.
    Runciman WB, Mather LE. Effects of anaesthesia on drug disposition. In: Feldman SA, Scurr CF, Paton W, eds. Drugs in anaesthesia. London: Edward Arnold, 1987:170–6.Google Scholar
  14. 14.
    Bundtzen RW, Gerber AU, Cohn DL, Craig WA. Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981, 3:28–32.PubMedGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1988

Authors and Affiliations

  • Alphonse J. M. Roex
    • 1
  • Arie C. van Loenen
    • 2
  1. 1.Department of Obstetrics and GynaecologyMedisch Centrum AlkmaarJD Alkmaarthe Netherlands
  2. 2.Department of Clinical PharmacyFree University HospitalHV Amsterdamthe Netherlands

Personalised recommendations